title: Predictors of good clinical outcome in acute stroke patients treated with intravenous thrombolysis.
abstract: OBJECTIVE
  Intravenous thrombolysis (IVT) is considered an effective treatment for acute ischemic stroke (IS). However, not all treated patients may achieve good outcome. The aim was to evaluate whether the initial NIHSS and DWI infarct volume could be the predictors for good outcome after IVT.
  
  
  METHODS
  The set of 125 patients with consecutive hemispheric IS (78 men; mean age 66.0 ± 12.1 years) treated with IVT within 3 h was analyzed. DWI volume was measured on admission. Good outcome was defined as a score 0-2 in modified Rankin Scale.
  
  
  RESULTS
  Multivariate logistic regression analysis showed initial NIHSS as an independent predictor of good outcome (P = 0.001). ROC curves showed baseline NIHSS ≤13.5 points and DWI volume ≤13.7 ml as cut-offs related to good outcome.
  
  
  CONCLUSIONS
  The initial NIHSS and DWI volume might be the predictors for good clinical outcome in acute stroke patients treated with IVT. The initial NIHSS score seems to be more accurate.
authors.affiliation: Stroke Center, Department of Neurology, Palacký University Medical School and University Hospital, Olomouc, Czech Republic. daniel.sanak@centrum.cz
authors.forename: D
authors.initials: D
authors.lastname: Saňák
authors.forename: R
authors.initials: R
authors.lastname: Herzig
authors.forename: J
authors.initials: J
authors.lastname: Zapletalová
authors.forename: D
authors.initials: D
authors.lastname: Horák
authors.forename: M
authors.initials: M
authors.lastname: Král
authors.forename: D
authors.initials: D
authors.lastname: Skoloudík
authors.forename: A
authors.initials: A
authors.lastname: Bártková
authors.forename: T
authors.initials: T
authors.lastname: Veverka
authors.forename: M
authors.initials: M
authors.lastname: Heřman
authors.forename: P
authors.initials: P
authors.lastname: Kaňovský
mesh_terms: D000368:Aged; D002545:Brain Ischemia / Q000188:drug therapy*; D038524:Diffusion Magnetic Resonance Imaging; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012372:ROC Curve; D012189:Retrospective Studies; D012720:Severity of Illness Index; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator